ライフサイエンスコーパス: limb salvage

1 cal management to maximize the potential for limb salvage.

2 verse outcomes after vein bypass surgery for limb salvage.

3 associated with decreased wound healing and limb salvage.

4 ate continuous arterial flow to the foot for limb salvage.

5 Complications occur more frequently in limb salvage.

6 urvival is equivalent between amputation and limb salvage.

7 s of EPC transplantation to improve ischemic limb salvage.

8 venous perfusion as an alternative method of limb salvage.

9 schemia is an important factor in maximizing limb salvage.

10 directly controllable factor associated with limb salvage.

11 29 consecutive diabetic patients in need of limb salvage.

12 yperglycemia, and advances in techniques for limb salvage.

13 essing need for innovative interventions for limb salvage.

14 ation between intensity of vascular care and limb salvage.

15 The treatment arms had similar incidence of limb salvage (55% for immediate surgery and 50% for pres

16 e administration of statins and longitudinal limb salvage after lower extremity endovascular revascul

17 statins were associated with improved 1-year limb salvage after lower extremity revascularization.

18 tients: 15 patients (15 limbs) evaluated for limb salvage and 15 patients (20 limbs) evaluated becaus

19 a is central to decisions between attempting limb salvage and amputation.

20 w number (10(3)) of CD34+KDR+ cells improved limb salvage and hemodynamic recovery better than a larg

21 rocedure that has exciting possibilities for limb salvage and merits further investigation.

22 Limb salvage and survival rates in patients treated with

23 yzed against the outcomes of a healed wound, limb salvage, and death.

24 nts and 1-year outcomes (vein graft patency, limb salvage, and patient survival).

25 eased tissue perfusion, functional recovery, limb salvage, and treadmill endurance compared to contro

26 mic hindlimb, and the effects on blood flow, limb salvage, and vascularization were assessed.

27 ty soft tissue sarcomas are treatable with a limb salvage approach, patients who develop a local recu

28 ed by significantly increased blood flow and limb salvage as measured serially for 4 wk.

29 ning to include patients being evaluated for limb salvage, as well as those being evaluated for claud

30 al, primary and secondary graft patency, and limb salvage at 5 years for the entire cohort were 70 +/

31 Limb salvage (avoidance of above-ankle amputation) was a

32 ge conduit arteries does not assure complete limb salvage because of severe microvascular disease.

33 There are benefits in terms of mortality and limb salvage both in the short-term and at 1 year postsu

34 ved postnatal neovascularization in terms of limb salvage by 4-fold in comparison with that of Td/GFP

35 death and major amputations, wound healing, limb salvage, clinically driven target-lesion revascular

36 Survival analysis demonstrated improved limb salvage during 1 year for statin users compared wit

37 the duration of limb ischemia and successful limb salvage following lower extremity arterial trauma.

38 Shh also augmented blood-flow recovery and limb salvage following operatively induced hind-limb isc

39 % reduction in the probability of successful limb salvage for every hour delay to revascularization.

40 Limb salvage for severe trauma has replaced amputation a

41 outcomes of those undergoing amputation and limb salvage have not been found to be substantially dif

42 Shock more than doubled the risk of failed limb salvage [hazard ratio=2.42 (95% confidence interval

43 HR, 1.49; 95% CI, 1.08 to 2.06; P=0.016) and limb salvage (HR, 2.02; 95% CI, 1.27 to 3.20; P=0.003) a

44 proved in 4 of 7 limbs, including successful limb salvage in 3 patients recommended for below-knee am

45 ecommend the use of these agents to maximize limb salvage in association with repair of popliteal art

46 apy increased perfusion, motor function, and limb salvage in old mice subjected to femoral artery lig

47 herford category), and (4) wound healing and limb salvage in patients presenting with critical limb i

48 PIER is a useful percutaneous technique for limb salvage in patients with CCLI.

49 er HGF plasmid can improve wound healing and limb salvage in patients with CLI are warranted.

50 An aggressive approach towards limb salvage in properly selected patients is justifiabl

51 Intravenous phage therapy was initiated as a limb-salvaging intervention.

52 Limb salvage is critically dependent on the duration of

53 With careful management, a high rate of limb salvage is practical for nonsmoking, nonuremic diab

54 90 days, amputation-free survival (AFS) and Limb salvage (LS) were noticeably worse in P2 compared t

55 PTA and surgery for limb salvage patients are indeed complementary procedure

56 donor sites in three patients who underwent limb salvage procedures for primary malignant bone tumor

57 sely associated for most patients undergoing limb salvage procedures.

58 ths after PIER, Kaplan-Meier analysis showed limb salvage rate was 66%, survival rate was 71%, and am

59 atients required a major amputation, and the limb salvage rate was 88.7%.

60 all limb-salvage rate was 83% and the 1-year limb-salvage rate was 75%.

61 The overall limb-salvage rate was 83% and the 1-year limb-salvage ra

62 not show any additional benefit in terms of limb salvage rates for patients undergoing vein bypass g

63 at variation in vascular practice may affect limb salvage rates in patients with severe peripheral ar

64 Two-year primary and secondary patencies and limb salvage rates were 37.4%, 55.4%, and 79.3% for pati

65 One- and two-year limb salvage rates were 64.2 and 53.8%.

66 is diminished in patients with limb-threat, limb-salvage rates remain reasonable at close to 80% at

67 rial bypass should improve wound healing and limb salvage, respectively.

68 Enhanced limb salvage resulted from comprehensive understanding o

69 Two hundred thirty patients (94%) underwent limb salvage surgery (arm A, 92%; arm B, 96%; P = .5).

70 peat peripheral intervention, amputation, or limb salvage surgery) within 6 months decreased by more

71 Limb-salvage surgery is now common and can be done for u

72 an-Meier curves were constructed to evaluate limb salvage, survival, and amputation-free survival.

73 Limb salvage was 100% in claudicants and overall limb sa

74 tation-free survival was 80% and 87% whereas limb salvage was 64% and 72% in P2 and P1, respectively)

75 ound healing was achieved in 56% and overall limb salvage was 80%.

76 The probability of limb salvage was 86.0% when ischemia was <=1 hour; 68.3%

77 salvage was 100% in claudicants and overall limb salvage was 92.4% per patient at 18 months and only

78 Limb salvage was improved with an arterial bypass (odds

79 At 90 days, amputation-free survival and limb salvage were noticeably worse in P2 compared to P1

80 MSCs substantially enhanced angiogenesis and limb salvage while reducing muscle degeneration and tiss

81 Secondary end points included limb salvage, wound healing, and technical success of th